Combination of factor vii and an anti-factor ix/x bispecific antibody
AssigneeLaboratoire Français du Fractionnnement et des Biotechnologies
InventorJean-Luc Plantier
Life of this patent
Estimating the term…
Abstract
The invention concerns a combination comprising transgenic factor VII and a multispecific antibody directed against factor IX and X, for simultaneous or separate administration.
Claims13
Pharmaceutical composition comprising:
- a. transgenic factor VII, and
- b. a multispecific antibody directed against factor IX and factor X,
Combination product comprising:
- a. transgenic factor VII, and
- b. a multispecific antibody directed against factor IX and factor X,
- for its use in preventing or treating a coagulation disorder in a patient.
Kit comprising
- A container containing transgenic factor FVII;
- and
- Another container containing an antibody directed against factor IX and factor X.
Method to treat a coagulation disorder in a patient, which method comprises the simultaneous or sequential administration to said patient of transgenic factor VII and a multispecific antibody directed against factor IX and factor X.
Use of a combination of transgenic factor VII and a multispecific antibody directed against factor IX and factor X for the treatment of a coagulation disorder in a patient, preferably hemophilia A, with factor VIII inhibitors.
Dependencies are inferred from the claim text.